Want to know about the latest trends within the world of biopharma? We spoke to Accenture’s life sciences practice lead, Barry Heavey, to find out.

Siliconrepublic.com editor John Kennedy headed down to BioPharma Ambition in February of this year to find out what’s happening in the industry.

Among the sector’s foremost experts was Barry Heavey, Accenture’s life sciences practice lead.

He spoke about the major trends that he is seeing coming down the line, including the increasing complexity of drugs, the speed of manufacturing and the personalisation of the medication.


Words by Jenny Darmody